DIAMEDICA THERAPEUTICS INC (DMAC) Institutional Ownership Changes & 13F Activity
DIAMEDICA THERAPEUTICS INC (DMAC). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Cooperman Leon G, Squarepoint Ops Llc, Goldman Sachs Group Inc, Millennium Management Llc, and Cobalt Capital Management, Inc..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +146 | +0.1% | 145,870 | $1.03M | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Sell | -1,356 | -73.8% | 481 | $3.39K | Q2 2026 | Aug 24, 2026 |
| Cooperman Leon G | Buy | +1,430,000 | +70.8% | 3,450,000 | $24.29M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +145,247 | — | 145,247 | $1.02M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +108,778 | +183.5% | 168,066 | $1.18M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -90,283 | -9.6% | 845,309 | $5.95M | Q2 2026 | Aug 14, 2026 |
| Cobalt Capital Management, Inc. | Buy | +90,000 | — | 90,000 | $633.60K | Q2 2026 | Aug 14, 2026 |
| Diametric Capital, Lp | Buy | +76,621 | — | 76,621 | $539.41K | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Buy | +62,387 | +280.3% | 84,648 | $595.92K | Q2 2026 | Aug 14, 2026 |
| Hsbc Holdings Plc | Buy | +34,224 | — | 34,224 | $244.70K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +20,962 | +131.3% | 36,928 | $259.97K | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +19,704 | — | 19,704 | $138.72K | Q2 2026 | Aug 14, 2026 |
| Osaic Holdings, Inc. | Buy | +18,432 | +5.8% | 338,107 | $2.38M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +15,096 | — | 15,096 | $106.28K | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +14,944 | +34.9% | 57,712 | $406.29K | Q2 2026 | Aug 14, 2026 |
| Metlife Investment Management, Llc | Buy | +8,517 | +71.8% | 20,380 | $143.47K | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +8,270 | +9.4% | 96,691 | $680.71K | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +7,322 | +31.6% | 30,492 | $215.00K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +6,658 | +102.6% | 13,145 | $92.54K | Q2 2026 | Aug 14, 2026 |
| Brevan Howard Capital Management Lp | Buy | +3,780 | +26.5% | 18,036 | $126.97K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +979 | +4.2% | 24,322 | $172.00K | Q2 2026 | Aug 14, 2026 |
| Legal & General Group Plc | Buy | +813 | +27.2% | 3,799 | $26.75K | Q2 2026 | Aug 14, 2026 |
| Mirae Asset Global Etfs Holdings Ltd. | Buy | +717 | +4.4% | 16,875 | $118.80K | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Sell | -160 | -1.4% | 11,127 | $78.33K | Q2 2026 | Aug 14, 2026 |
| Aquatic Capital Management Llc | Buy | +11 | — | 11 | $77.00 | Q2 2026 | Aug 14, 2026 |
| Morgan Stanley | Sell | -58,546 | -55.5% | 46,874 | $329.99K | Q2 2026 | Aug 13, 2026 |
| Vanguard Portfolio Management Llc | Buy | +48,212 | +23.7% | 251,671 | $1.77M | Q2 2026 | Aug 13, 2026 |
| Vanguard Capital Management Llc | Buy | +22,067 | +6.6% | 355,523 | $2.50M | Q2 2026 | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +19,714 | +10.5% | 207,438 | $1.46M | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Buy | +14,188 | +163.8% | 22,849 | $160.86K | Q2 2026 | Aug 13, 2026 |
Frequently asked questions about DMAC activity
Which institutional owners are buying DMAC?
Institutional owners buying DMAC include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in DMAC activity?
"Buy" means an investor increased their reported position in DMAC compared to the prior reporting period. This reflects growing exposure to DIAMEDICA THERAPEUTICS INC (DMAC) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in DMAC increasing?
Institutional interest in DMAC can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related DMAC Institutional Insights
- DMAC Overview
- DMAC 13F Institutional Holders
- DMAC Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- DMAC Insider Trading & SEC Form 4 Activity
- DMAC Articles
- Top Institutional Investor Stock Rankings